射血分数保留的心力衰竭中微血管功能障碍的患病率与预后意义
前瞻性观察研究纳入101例射血分数保留的心力衰竭(HFpEF)患者和43例对照,用多参数心脏磁共振评估灌注与纤维化。HFpEF患者心肌灌注储备(MPR)低于对照(1.74±0.76 vs 2.22±0.76,P=0.001),微血管功能障碍(MPR<2.0)占70%。MPR经多因素校正后独立预测死亡或心衰住院复合终点。
要点
- HFpEF患者MPR为1.74±0.76,低于对照的2.22±0.76(P=0.001)。
- 以MPR<2.0定义微血管功能障碍,HFpEF患者中占70%,对照中占48%(P=0.014)。
- MPR与弥漫性纤维化无显著线性相关(r=-0.10,P=0.473)。
核心结论
- 微血管功能障碍在HFpEF患者中高度流行,且是预后的独立预测因子;微血管功能障碍与纤维化缺乏相关性,可能挑战两者存在直接因果联系的论断。
研究设计与样本
- 前瞻性观察研究,纳入101例HFpEF患者(平均年龄73±9岁,平均射血分数56%±5%)和43例对照(平均年龄73±5岁,平均射血分数58%±5%),行多参数心脏磁共振评估左心室容积、灌注及纤维化(局灶性用晚期钆增强,弥漫性用细胞外容积)。
诊断标准与关键数值
- 微血管功能障碍定义为心肌灌注储备(MPR)<2.0。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The pathophysiological and clinical significance of microvascular dysfunction (MVD) in patients with heart failure with preserved ejection fraction (HFpEF) remains uncertain.
OBJECTIVES: The aim of this study was to use cardiovascular magnetic resonance to: 1) quantify coronary microvascular function; 2) examine the relationship between perfusion and fibrosis; and 3) evaluate the impact of MVD and fibrosis on long-term clinical outcomes.
METHODS: In a prospective, observational study, patients with HFpEF and control subjects underwent multiparametric cardiovascular magnetic resonance (comprising assessment of left ventricular volumetry, perfusion, and fibrosis [focal by late gadolinium enhancement and diffuse by extracellular volume]). The primary endpoint was the composite of death or hospitalization with heart failure.
RESULTS: One hundred and one patients with HFpEF (mean age 73 ± 9 years, mean ejection fraction 56% ± 5%) and 43 control subjects (mean age 73 ± 5 years, mean ejection fraction 58% ± 5%) were studied. Myocardial perfusion reserve (MPR) was lower in patients with HFpEF versus control subjects (1.74 ± 0.76 vs 2.22 ± 0.76; P = 0.001). MVD (defined as MPR <2.0) was present in 70% of patients with HFpEF (vs 48% of control subjects; P = 0.014). There was no significant linear correlation between MPR and diffuse fibrosis (r = -0.10; P = 0.473) and no difference in MPR between those with and without focal fibrosis (mean difference -0.03; 95% CI: -0.37 to 0.30). In the HFpEF group, during median follow-up of 3.1 years, there were 45 composite events. MPR was independently predictive of clinical outcome following adjustment for clinical, blood, and imaging parameters (1 SD increase: HR: 0.673 [95% CI: 0.463 to 0.978; P = 0.038]; HR: 0.694 [95% CI: 0.491 to 0.982; P = 0.039]; and HR: 0.690 [95% CI: 0.489 to 0.973; P = 0.034], respectively).
CONCLUSIONS: MVD is highly prevalent among patients with HFpEF and is an independent predictor of prognosis. The lack of correlation between MVD and fibrosis may challenge the assertion of a direct causal link between these entities. (Developing Imaging and Plasma Biomarkers in Describing Heart Failure With Preserved Ejection Fraction [DIAMONDHFpEF]; NCT03050593).
引用
- Arnold JR, Kanagala P, Budgeon CA, et al. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. JACC Cardiovasc Imaging. 2022. PMID: 35033490. doi:10.1016/j.jcmg.2021.11.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。